Premium
Heartflow Inc (HTFL)
NASDAQ
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
| Date | Nom du détenteur | Actions transigées | Fourchette de valeur ($) | Type d'opération | Fourchette de prix ($) | Actions en fin de déclaration | % de variation |
|---|---|---|---|---|---|---|---|
| 2026-06-10 | Mr. John C.M. FarquharPresident, CEO & Director | -22,56k | 643,02k | Automatic Disposition | 28,50 | 496,84k | -4,34% |
| 2026-05-18 | Dr. Campbell D.K. RogersChief Medical Officer & Exec. VP | -9,22k | 86,11k | Derivative Exercise and Sale | 19,00 - 28,34 | 224,27k | - |
| 2026-05-11 | Mr. John C.M. FarquharPresident, CEO & Director | -22,56k | 657,01k | Automatic Disposition | 29,12 | 519,40k | -4,16% |
| 2026-05-06 | Mr. John C.M. FarquharPresident, CEO & Director | -7,20k | 217,62k | Sale to Issuer | 29,98 - 30,29 | 541,96k | -1,31% |
| 2026-04-28 | Bain Capital Life Sciences Investors, LLCSociété | -2,00M | 58,90M | Vente | 29,18 - 30,51 | 8,45M | -19,14% |
| 2026-04-10 | Mr. John C.M. FarquharPresident, CEO & Director | -22,56k | 602,86k | Automatic Disposition | 26,72 | 549,16k | -3,95% |
| 2026-04-01 | Dr. Campbell D.K. RogersChief Medical Officer & Exec. VP | -64,53k | 1,45M | Derivative Exercise and Sale | 2,22 - 24,64 | 154,05k | - |
| 2026-04-01 | Dr. Campbell D.K. RogersChief Medical Officer & Exec. VP | 2,48k | 7,29k | Derivative Exercise and Retained Stock | 2,22 - 8,33 | 154,05k | 1,64% |
| 2026-03-24 | HealthCor Management L.P.Société | -4,62M | 0,00 | Other Disposition | - | 0,00 | -100,00% |
| 2026-03-19 | Dr. Campbell D.K. RogersChief Medical Officer & Exec. VP | -64,53k | 1,51M | Derivative Exercise and Sale | 2,22 - 25,69 | 151,57k | - |
| 2026-03-19 | Dr. Campbell D.K. RogersChief Medical Officer & Exec. VP | 2,48k | 5,51k | Derivative Exercise and Retained Stock | 2,22 | 151,57k | 1,67% |
| 2026-03-18 | Mr. John C.M. FarquharPresident, CEO & Director | -9,73k | 243,13k | Automatic Disposition | 25,00 | 571,73k | -1,67% |
| 2026-03-11 | Mr. Timothy C. BarabeIndependent Director | 8,67k | 19,24k | Derivative Exercise and Retained Stock | 2,22 | 179,52k | 5,07% |
| 2026-03-10 | Mr. John C.M. FarquharPresident, CEO & Director | -12,84k | 290,89k | Vente | 22,66 | 236,24k | -5,15% |
| 2026-03-05 | Ms. Julie Anne CullivanIndependent Director | -9,12k | 228,05k | Automatic Disposition | 25,00 | 27,29k | -25,05% |
| 2026-02-17 | Mr. Timothy C. BarabeIndependent Director | 2,50k | 20,80k | Derivative Exercise and Retained Stock | 8,33 | 170,85k | 1,48% |
| 2026-02-12 | Dr. Campbell D.K. RogersChief Medical Officer & Exec. VP | 1,86k | 4,14k | Derivative Exercise and Retained Stock | 2,22 | 149,08k | 1,27% |
| 2026-02-12 | Dr. Campbell D.K. RogersChief Medical Officer & Exec. VP | -65,15k | 1,21M | Derivative Exercise and Sale | 2,22 - 24,49 | 149,08k | - |
| 2026-02-06 | Ms. Mhairi L. JonesInitié | -94,00 | 2,61k | Sale to Issuer | 27,74 | 6,86k | -1,35% |
| 2026-02-10 | Mr. John C.M. FarquharPresident, CEO & Director | -22,56k | 619,55k | Automatic Disposition | 27,46 | 355,42k | -5,97% |
| 2026-02-06 | Mr. John C.M. FarquharPresident, CEO & Director | -1,54k | 42,75k | Sale to Issuer | 27,74 | 355,42k | -0,43% |
| 2026-02-06 | Dr. Campbell D.K. RogersChief Medical Officer & Exec. VP | -515,00 | 14,29k | Sale to Issuer | 27,74 | 147,22k | -0,35% |
| 2026-02-06 | Mr. Vikram VergheseCFO | -542,00 | 15,04k | Sale to Issuer | 27,74 | 125,95k | -0,43% |
| 2026-02-05 | Ms. Julie Anne CullivanIndependent Director | -8,00k | 218,56k | Automatic Disposition | 27,32 | 36,41k | -18,01% |
| 2026-02-04 | Bain Capital Life Sciences Investors, LLCSociété | -2,00M | 56,10M | Vente | 28,05 | 10,45M | -16,07% |
| 2025-12-16 | HealthCor Management L.P.Société | 40,00k | 1,05M | Achat | 26,34 | 6,74M | 0,60% |
| 2025-11-07 | Dr. Campbell D.K. RogersChief Medical Officer & Exec. VP | -439,00 | 14,29k | Sale to Issuer | 32,56 | 146,42k | -0,30% |
| 2025-11-07 | Mr. John C.M. FarquharPresident, CEO & Director | -1,34k | 43,60k | Sale to Issuer | 32,56 | 375,78k | -0,36% |
| 2025-11-07 | Mr. Vikram VergheseCFO | -471,00 | 15,34k | Sale to Issuer | 32,56 | 125,18k | -0,37% |
| 2025-11-07 | Ms. Mhairi L. JonesInitié | -81,00 | 2,64k | Sale to Issuer | 32,56 | 6,72k | -1,19% |
| 2025-08-11 | Bain Capital Life Sciences Investors, LLCSociété | 12,45M | 6,60M | Derivative Exercise and Retained Stock | 15,20 | 12,45M | - |
| 2025-08-11 | Mr. William C. WeldonIndependent Chairman of the Board | 136,29k | 0,00 | Derivative Exercise and Retained Stock | - | 192,56k | 242,17% |
| 2025-08-11 | Mr. Timothy C. BarabeIndependent Director | 131,58k | 0,00 | Derivative Exercise and Retained Stock | - | 168,36k | 357,75% |
| 2025-08-11 | USVP Management Company, LLCSociété | 3,19M | 0,00 | Derivative Exercise and Retained Stock | - | 3,19M | - |
| 2025-08-11 | Ms. Mhairi L. JonesInitié | 6,58k | 0,00 | Derivative Exercise and Retained Stock | - | 6,58k | - |
| 2025-08-11 | Mr. Vikram VergheseCFO | 9,52k | 0,00 | Derivative Exercise and Retained Stock | - | 124,33k | 8,29% |
| 2025-08-11 | HealthCor Management L.P.Société | 6,70M | 0,00 | Derivative Exercise and Retained Stock | - | 6,70M | - |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
